These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26269470)

  • 1. Practical details, confirmed safety and new targets.
    Picard J; Leen E
    Br J Anaesth; 2015 Sep; 115(3):472-3. PubMed ID: 26269470
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply from the authors. Anaesthetic management during open and percutaneous irreversible electroporation.
    Nielsen K; Scheffer HJ; Vieveen JM; van den Tol P; Meijerink MR; Bouwman RA
    Br J Anaesth; 2015 Sep; 115(3):473-4. PubMed ID: 26269471
    [No Abstract]   [Full Text] [Related]  

  • 3. Anesthesia for irreversible electroporation of hepatic malignant tumors.
    Trabold B; Wiggermann P; Akyol D; Jung EM; Nießen C; Stroszczynski C; Graf BM; Wiese C
    J Clin Anesth; 2013 Aug; 25(5):430-431. PubMed ID: 23965203
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaesthetic management during open and percutaneous irreversible electroporation.
    Nielsen K; Scheffer HJ; Vieveen JM; van Tilborg AA; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR; Bouwman RA
    Br J Anaesth; 2014 Dec; 113(6):985-92. PubMed ID: 25173767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan.
    Sugimoto K; Moriyasu F; Kobayashi Y; Saito K; Takeuchi H; Ogawa S; Ando M; Sano T; Mori T; Furuichi Y; Nakamura I
    Jpn J Radiol; 2015 Jul; 33(7):424-32. PubMed ID: 26032929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthetic management of patients undergoing percutaneous irreversible electroporation.
    Saito T
    J Clin Anesth; 2019 Dec; 58():27-28. PubMed ID: 31055197
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible electroporation: ready for prime time?
    Lu DS; Kee ST; Lee EW
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):277-86. PubMed ID: 24238383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial on focal therapy for localized prostate carcinoma: hemiablation versus complete ablation with irreversible electroporation.
    van den Bos W; Muller BG; de la Rosette JJ
    J Endourol; 2013 Mar; 27(3):262-4. PubMed ID: 23469828
    [No Abstract]   [Full Text] [Related]  

  • 9. Postloco-Regional Therapy Imaging of the Liver.
    Kwok N; Lee SR; Arellano RS
    Semin Roentgenol; 2016 Oct; 51(4):378-383. PubMed ID: 27743572
    [No Abstract]   [Full Text] [Related]  

  • 10. SI: Irreversible Electroporation (IRE). Introduction.
    Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):127. PubMed ID: 26365540
    [No Abstract]   [Full Text] [Related]  

  • 11. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
    Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Image-Guided Percutaneous Ablation of Breast Cancer.
    Fleming MM; Holbrook AI; Newell MS
    AJR Am J Roentgenol; 2017 Feb; 208(2):267-274. PubMed ID: 27762603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage.
    Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB
    World J Urol; 2017 Jan; 35(1):11-20. PubMed ID: 27147512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Irreversible Electroporation for Recurrent Thyroid Cancer--A Case Report.
    Meijerink MR; Scheffer HJ; de Bree R; Sedee RJ
    J Vasc Interv Radiol; 2015 Aug; 26(8):1180-2. PubMed ID: 26210244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.
    van den Bos W; Jurhill RR; de Bruin DM; Savci-Heijink CD; Postema AW; Wagstaff PG; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna Pes MP; de Reijke TM; de la Rosette JJ
    J Urol; 2016 Aug; 196(2):552-9. PubMed ID: 27004693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma.
    Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L
    Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on irreversible electroporation of liver tumours.
    Yeung ES; Chung MW; Wong K; Wong CY; So EC; Chan AC
    Hong Kong Med J; 2014 Aug; 20(4):313-6. PubMed ID: 24914075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New tumor ablation techniques for cancer treatment (microwave, electroporation).
    de Baere T; Deschamps F
    Diagn Interv Imaging; 2014; 95(7-8):677-82. PubMed ID: 24818966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niche Applications of Irreversible Electroporation.
    Bhatia SS; Arya R; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):170-5. PubMed ID: 26365547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.